Next week, let’s connect in Copenhagen!
From April 13 to 15, Giedrius Gasiunas, CEO of Caszyme, will be attending the CRISPR Medicine News Conference 2026.
April 14 | 3:48 PM – Giedrius will present the latest data on Cas12l, offering new insights into Caszyme’s proprietary CRISPR-Cas platform.
If you’re interested in Cas12l or would like to exchange ideas on CRISPR-based solutions, this is an excellent opportunity to connect!
Feel free to reach out to arrange a meeting – we look forward to seeing you in Copenhagen!